JP2021524850A5 - - Google Patents

Info

Publication number
JP2021524850A5
JP2021524850A5 JP2020564431A JP2020564431A JP2021524850A5 JP 2021524850 A5 JP2021524850 A5 JP 2021524850A5 JP 2020564431 A JP2020564431 A JP 2020564431A JP 2020564431 A JP2020564431 A JP 2020564431A JP 2021524850 A5 JP2021524850 A5 JP 2021524850A5
Authority
JP
Japan
Prior art keywords
disease
compound
disorders
pharmaceutical composition
equation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020564431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021524850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/032555 external-priority patent/WO2019222438A1/en
Publication of JP2021524850A publication Critical patent/JP2021524850A/ja
Publication of JP2021524850A5 publication Critical patent/JP2021524850A5/ja
Pending legal-status Critical Current

Links

JP2020564431A 2018-05-17 2019-05-16 RORγ調節剤としての三環スルホン化合物 Pending JP2021524850A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862672802P 2018-05-17 2018-05-17
US62/672,802 2018-05-17
PCT/US2019/032555 WO2019222438A1 (en) 2018-05-17 2019-05-16 Tricyclic sulfone compound as a ror gamma modulator

Publications (2)

Publication Number Publication Date
JP2021524850A JP2021524850A (ja) 2021-09-16
JP2021524850A5 true JP2021524850A5 (cg-RX-API-DMAC10.html) 2022-05-19

Family

ID=66691023

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564431A Pending JP2021524850A (ja) 2018-05-17 2019-05-16 RORγ調節剤としての三環スルホン化合物

Country Status (6)

Country Link
US (1) US10633339B2 (cg-RX-API-DMAC10.html)
EP (1) EP3793978A1 (cg-RX-API-DMAC10.html)
JP (1) JP2021524850A (cg-RX-API-DMAC10.html)
KR (1) KR102829200B1 (cg-RX-API-DMAC10.html)
CN (1) CN112119060A (cg-RX-API-DMAC10.html)
WO (1) WO2019222438A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12570609B2 (en) 2020-01-24 2026-03-10 Bristol-Myers Squibb Company Tricyclic sulfones as ROR gamma modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059075A1 (es) * 2006-01-20 2008-03-12 Schering Corp Bencesulfonil - cromano , tiocromano tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
WO2012052451A1 (en) * 2010-10-18 2012-04-26 Merz Pharma Gmbh & Co. Kgaa Metabotropic glutamate receptor modulators
CN107709295B (zh) 2015-05-07 2021-05-04 百时美施贵宝公司 作为RORγ调节剂的三环砜类
WO2018071620A1 (en) 2016-10-13 2018-04-19 Bristol-Myers Squibb Company Heterocyclic sulfones as ror gamma modulators

Similar Documents

Publication Publication Date Title
Janssens et al. Pathological roles of the homeostatic chemokine CXCL12
JP2023506147A5 (cg-RX-API-DMAC10.html)
JP2024516371A5 (cg-RX-API-DMAC10.html)
JP2024071370A5 (cg-RX-API-DMAC10.html)
JP2017079785A5 (cg-RX-API-DMAC10.html)
JP2019524822A5 (cg-RX-API-DMAC10.html)
JP2017509689A5 (cg-RX-API-DMAC10.html)
JP2019532078A5 (cg-RX-API-DMAC10.html)
JP2016199576A5 (cg-RX-API-DMAC10.html)
HRP20161010T1 (hr) C5ar antagonisti
JP2019515924A5 (cg-RX-API-DMAC10.html)
JP2022550640A5 (cg-RX-API-DMAC10.html)
JP2018140982A5 (cg-RX-API-DMAC10.html)
JP2018536634A5 (cg-RX-API-DMAC10.html)
JP2019529514A5 (cg-RX-API-DMAC10.html)
JP2013529647A5 (cg-RX-API-DMAC10.html)
JP2017528506A5 (cg-RX-API-DMAC10.html)
JP2006510676A5 (cg-RX-API-DMAC10.html)
JP2023085290A (ja) PI3K-γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体
CN110770233A (zh) 稠合双环类化合物及其在药物中的应用
JP2016164177A5 (cg-RX-API-DMAC10.html)
JP2020502047A5 (cg-RX-API-DMAC10.html)
JP2021500403A5 (cg-RX-API-DMAC10.html)
JP2007522142A5 (cg-RX-API-DMAC10.html)
JP2020534346A5 (cg-RX-API-DMAC10.html)